ClinicalTrials.gg
DrugRead study by study

Cagrilintide clinical trials

Also written NNC0174-0833.

studies test it
50
open now
11
in phase 3
23
first study started
2014
ClinicalTrials.gov finds 45 studies for cagrilintide. How that becomes 50 here

Every study that search finds has been read, to see whether and how it gives cagrilintide. ClinicalTrials.gov counts as of Nov 16, 2026. How drug pages count

  1. 45Found by its intervention search · See all 45 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 41 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. +7Give it under a name that search misses: a biosimilar’s code or a misspelling
  3. 52Give cagrilintide to participants
  4. −1Compare another treatment with it
  5. −1Give it beside what is tested
  6. 50Test it: the count on this site

Get an email when these change. Save the cagrilintide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cagrilintide
29
CagriSema
5
CagriSema (Cagrilintide B and Semaglutide I)
4
Cagrilintide D
2

Development codes

NNC0174-0833
8

In one entry with another drug

Given together, or one or the other

Cagrilintide and Semaglutide
2

Studies by the year they started

50 studies that test it; most in 2026 (13)

Studies that test cagrilintide, by start year
YearStudies
20141
20161
20181
20193
20201
20212
20221
20238
202412
20257
202613

By phase

A phase 1/2 study counts in both.

Phase 1
21
Phase 2
6
Phase 3
23

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 50 · Other 0

Novo Nordisk A/S (50)

Often tested with

Tested in the same studies.

Semaglutide (3) · Atorvastatin (1) · Warfarin (1) · Zalfermin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

New treatments tested with it · 1 most studied

New when their studies opened, with cagrilintide beside them; studies of each.

Reaching primary completion within a year · 10, 6 in phase 3

Studies that test cagrilintide, phase 3 first.

Studies

Open first, then newest update. How each study uses cagrilintide has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 50

See all 50 studies that test cagrilintide →

Tested on its own · 19 — no other medicine in its arm
Tested with established drugs · 26 — they are given beside it

Showing 20 of 26. See all 26 →

Tested in a combination · 5 — another drug in the study is under test too
Beside a new treatment under test · 1 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with cagrilintide: Gastric Inhibitory Polypeptide 1

As the comparator · 1 — what is tested is compared with cagrilintide

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call cagrilintide · ClinicalTrials.gg INT001638

  • MeSH (NLM) C000717792cagrilintideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) AO43BIF1U8CAGRILINTIDEConfirmed FDA, NLM
  • NCI Thesaurus C175752CagrilintideOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion